This inventor holds 105 USPTO granted patents, primarily in tRNA Synthetase (CPC class 4353201). Top assignees: Smithkline Beecham Corporation, Affinium Pharmaceuticals, Inc., Replidyne, Inc.. Active years: 1997-2008.
Inventors with similar research interests:
Location History:
- Cumbria, GB (2001)
- Carlisle, GB (2001)
- King of Prussia, PA (US) (2002)
- Paris, FR (2002)
- Malvern, PA (US) (1997 - 2008)
Company Filing History:
81 out of 2,198 
3 out of 33 
3 out of 12 Years Active: 1997-2008
Areas of Expertise:
Sure, I can help you with that. Here is the article about inventor John Edward Hodgson:
Title: Unveiling the Innovative Journey of Inventor John Edward Hodgson
Introduction:
In the realms of innovation, one name shines brightly - John Edward Hodgson. Hailing from Malvern, PA, John Edward Hodgson has left an indelible mark on the world of inventions with a remarkable 105 patents to his credit.
Latest Patents:
Among his latest patents, two groundbreaking inventions stand out:
1. Compounds: This invention focuses on newly identified Staphylococcal polynucleotides and polypeptides, their uses, production, and inhibiting their biosynthesis or action for therapeutic purposes.
2. tRNA synthetase: Bringing forth tRNA synthetase polypeptides and DNA (RNA) encoding them, this invention provides methods for producing such polypeptides and utilizing them for protection against bacterial infections.
Career Highlights:
John Edward Hodgson's innovative spirit has graced renowned companies such as SmithKline Beecham Corporation, showcasing his prowess in driving cutting-edge research and development in the field of life sciences.
Collaborations:
Throughout his illustrious career, John Edward Hodgson has collaborated with esteemed individuals like Michael Terence Black and Richard Oakley Nicholas, fostering a culture of innovation and excellence in his professional endeavors.
Conclusion:
In conclusion, John Edward Hodgson's impact on the world of inventions is profound and enduring. His relentless pursuit of innovation and collaboration has not only transformed the landscape of life sciences but has also inspired a generation of inventors to push the boundaries of what is possible. John Edward Hodgson stands as a testament to the power of ingenuity and dedication in shaping a brighter future for us all.